Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth
- PMID: 10189890
- PMCID: PMC5926055
- DOI: 10.1111/j.1349-7006.1999.tb00733.x
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth
Abstract
To determine the role of the Wilms' tumor gene WT1 in tumorigenesis of solid tumors, expression of the WT1 gene was examined in 34 solid tumor cell lines (four gastric cancer cell lines, five colon cancer cell lines, 15 lung cancer cell lines, four breast cancer cell lines, one germ cell tumor cell line, two ovarian cancer cell lines, one uterine cancer cell line, one thyroid cancer cell line, and one hepatocellular carcinoma cell line) by means of quantitative reverse transcriptase-polymerase chain reaction. WT1 gene expression was detected in three of the four gastric cancer cell lines, all of the five colon cancer cell lines, 12 of the 15 lung cancer cell lines, two of the four breast cancer cell lines, the germ cell tumor cell line, the two ovarian cancer cell lines, the uterine cancer cell line, the thyroid cancer cell line, and the hepatocellular carcinoma cell line. Therefore, of the 34 solid tumor cell lines examined, 28 (82%) expressed WT1. Three cell lines expressing WT1 (gastric cancer cell line AZ-521, lung cancer cell line OS3, and ovarian cancer cell line TYK-nu) were further analyzed for mutations and/or deletions in the WT1 gene by means of single-strand conformation polymorphism analysis. However, no mutations or deletions were detected in the region of the WT1 gene ranging from the 3' end of exon 1 to exon 10 (the WT1 gene consists of 10 exons) in these three cell lines. Furthermore, when AZ-521, OS3, and TYK-nu cells were treated with WT1 antisense oligomers, the growth of these cells was significantly inhibited in association with a reduction in WT1 protein levels. Furthermore, constitute expression of the transfected WT1 gene in cancer cells inhibited the antisense effect of WT1 antisense oligomer on cell growth. These results indicated that the WT1 gene plays an essential role in the growth of solid tumors and performs an oncogenic rather than a tumor-suppressor gene function.
Similar articles
-
Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.Int J Oncol. 2008 Mar;32(3):701-11. Int J Oncol. 2008. PMID: 18292948
-
Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.Cancer Sci. 2006 Apr;97(4):259-70. doi: 10.1111/j.1349-7006.2006.00169.x. Cancer Sci. 2006. PMID: 16630117 Free PMC article.
-
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.Am J Pathol. 1995 Feb;146(2):344-56. Am J Pathol. 1995. PMID: 7856747 Free PMC article.
-
Wilms tumor and the WT1 gene.Exp Cell Res. 2001 Mar 10;264(1):74-99. doi: 10.1006/excr.2000.5131. Exp Cell Res. 2001. PMID: 11237525 Review.
-
Wilms' tumor gene WT1: its oncogenic function and clinical application.Int J Hematol. 2001 Feb;73(2):177-87. doi: 10.1007/BF02981935. Int J Hematol. 2001. PMID: 11372729 Review.
Cited by
-
Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors.Cancer Sci. 2004 Oct;95(10):822-7. doi: 10.1111/j.1349-7006.2004.tb02188.x. Cancer Sci. 2004. PMID: 15504250 Free PMC article.
-
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma.Int J Hematol. 2007 Dec;86(5):414-7. doi: 10.1007/BF02983998. Int J Hematol. 2007. PMID: 18192109
-
Non-natural and photo-reactive amino acids as biochemical probes of immune function.PLoS One. 2008;3(12):e3938. doi: 10.1371/journal.pone.0003938. Epub 2008 Dec 15. PLoS One. 2008. PMID: 19079589 Free PMC article.
-
Peptide Based Vaccine Approaches for Cancer-A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen.Cancers (Basel). 2011 Oct 25;3(4):3991-4009. doi: 10.3390/cancers3043991. Cancers (Basel). 2011. PMID: 24213121 Free PMC article.
-
Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood.Int J Hematol. 2016 Jan;103(1):53-62. doi: 10.1007/s12185-015-1882-1. Epub 2015 Oct 31. Int J Hematol. 2016. PMID: 26520650
References
-
- ) Call , K. M. , Glaser , T. , Ito , C. Y. , Buckler , A. J. , Pelletier , J. , Haber , D. A. , Rose , E. A. , Kral , A. , Yeger , H. , Lewis , W. H. , Jones , C. and Housman , D. E.Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus . Cell , 60 , 509 – 520 ( 1990. ). - PubMed
-
- ) Gessler , M. , Poustka , A. , Cavenee , W. , Neve , R. L. , Orkin , S. H. and Bruns , G. A. P.Homozygous deletion in Wilms tumours of a zinc‐finger gene identified by chromosome jumping . Nature , 343 , 774 – 778 ( 1990. ). - PubMed
-
- ) Harrington , M. A. , Konicek , B. , Song , A. , Xia , X.‐L. , Fredericks , W. J. and Rauscher , F. J. , IIIInhibition of colony‐stimulating factor‐1 promoter activity by the product of the Wilms' tumor locus . J. Biol. Chem. , 268 , 21271 – 21275 ( 1993. ). - PubMed
-
- ) Drummond , I. A. , Madden , S. L. , Rohwer‐Nutter , P. , Bell , G. I. , Sukhatme , V. P. and Rauscher , F. J. , IIIRepression of the insulin‐like growth factor II gene by the Wilms tumor suppressor WT1 . Science , 257 , 674 – 678 ( 1992. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials